In vitro anti-mesothelioma activity of cisplatin–gemcitabine combinations: evidence for sequence-dependent effects

被引：0
|
作者：
Ilaria Zanellato
Carla Doriana Boidi
Guido Lingua
Pier-Giacomo Betta
Sara Orecchia
Elena Monti
Domenico Osella
机构：
[1] Università del Piemonte Orientale “Amedeo Avogadro”,Department of Environmental and Life Sciences
[2] Pathology Unit,Department of Structural and Functional Biology, Section of Pharmacology
[3] Department of Oncology,undefined
[4] Azienda Sanitaria Ospedaliera,undefined
[5] University of Insubria,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2011年 / 67卷
关键词：
Malignant pleural mesothelioma; Cisplatin; Gemcitabine; Combination chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：265 / 273
页数：8
相关论文
共 22 条
  • [1] In vitro anti-mesothelioma activity of cisplatin-gemcitabine combinations: evidence for sequence-dependent effects
    Zanellato, Ilaria
    Boidi, Carla Doriana
    Lingua, Guido
    Betta, Pier-Giacomo
    Orecchia, Sara
    Monti, Elena
    Osella, Domenico
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (02) : 265 - 273
  • [2] SEQUENCE-DEPENDENT CYTOTOXIC EFFECTS DUE TO COMBINATIONS OF CISPLATIN AND THE ANTIMICROTUBULE AGENTS TAXOL AND VINCRISTINE
    ROWINSKY, EK
    CITARDI, MJ
    NOE, DA
    DONEHOWER, RC
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1993, 119 (12) : 727 - 733
  • [3] SEQUENCE-DEPENDENT GROWTH-INHIBITORY EFFECTS OF THE IN-VITRO COMBINATION OF FLUOROURACIL, CISPLATIN, AND DIPYRIDAMOLE
    BARBERIHEYOB, M
    GRIFFON, G
    MERLIN, JL
    WEBER, B
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1993, 33 (02) : 163 - 170
  • [4] SEQUENCE-DEPENDENT ANTITUMOR-ACTIVITY OF PACLITAXEL (TAXOL) AND CISPLATIN IN-VIVO
    MILROSS, CG
    PETERS, LJ
    HUNTER, NR
    MASON, KA
    MILAS, L
    INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (05) : 599 - 604
  • [5] Potent Anti-Mesothelioma Activity by the Novel Naftopidil Analogue HUHS1015; Preclinical Evidence for Treatment
    Kuribayashi, Kozo
    Ieki, Ryuji
    Otsuki, Taiichiro
    Gotoh, Akinobu
    Tanaka, Akito
    Nishizaki, Tomoyuki
    Nakano, Takashi
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S352 - S352
  • [6] Sequence-dependent effect of gemcitabine and cisplatin on A549 non-small-cell lung cancer cells
    Tang, Yu
    Wang, Yan
    Teng, Xiuzhi
    MOLECULAR MEDICINE REPORTS, 2013, 8 (01) : 221 - 226
  • [7] Sequence-dependent hematologic side effects of topotecan and cisplatin in persistent or recurrent cervical cancer
    Lee, Yoo-Young
    Lee, Jeong-Won
    Park, Hwang Shin
    Song, Tae Jong
    Kim, Min Kyu
    Choi, Chel Hun
    Kim, Tae-Joong
    Lee, Je-Ho
    Bae, Duk-Soo
    Kim, Byoung-Gie
    GYNECOLOGIC ONCOLOGY, 2010, 119 (01) : 87 - 91
  • [8] Pharmacodynamic Modeling of Sequence-Dependent Antitumor Activity of Insulin-like Growth Factor Blockade and Gemcitabine
    Amit Khatri
    Richard C. Brundage
    Jessica M. Hull
    Brent W. Williams
    Douglas Yee
    Mark N. Kirstein
    The AAPS Journal, 2012, 14 : 1 - 9
  • [9] Pharmacodynamic Modeling of Sequence-Dependent Antitumor Activity of Insulin-like Growth Factor Blockade and Gemcitabine
    Khatri, Amit
    Brundage, Richard C.
    Hull, Jessica M.
    Williams, Brent W.
    Yee, Douglas
    Kirstein, Mark N.
    AAPS JOURNAL, 2012, 14 (01): : 1 - 9
  • [10] Sequence-dependent effects of hematoporphyrin derivatives (HPD) photodynamic therapy and cisplatin on lung adenocarcinoma cells
    Li, Nana
    Cui, Shichao
    Yang, Aizhen
    Xiao, Baohong
    Cao, Yiwei
    Yang, Xiaohui
    Lin, Cunzhi
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2024, 47
123